International Neuromodulation Society Guidelines for Intrathecal Drug Delivery from the Polyanalgesic Consensus Conference (PACC)
SmartMobile(TM)Premiere Date: Friday, June 22, 2018
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Monday, April 26, 2021
|Timothy R. Deer, MD, DABPM, FIPP
President and CEO
The Spine and Nerve Centers of the Virginias and the Center for Pain Relief, Inc.
Department of Anesthesiology
West Virginia University School of Medicine
|Gladstone C. McDowell II, MD
Integrated Pain Solutions
Remembering guidelines, practice algorithms, and other clinical recommendations can be a challenge for busy clinicians. Luckily, when it comes to pain management, there's an APP for that!
The mission of the International Neuromodulation Society (INS) and the Polyanalgesic Consensus Conference (PACC) is to use current literature and clinical knowledge to provide recommendations that support safety and efficacy in patients with refractory chronic pain and who are candidates for intrathecal therapy. The new PACC recommendations reflect updated guidance and practice algorithms to meet current gaps in practice, and physicians should use these guidelines when implementing intrathecal therapy in order to improve patient care through application of evidence-based treatment.
This versatile mobile application from INS and CME Outfitters features an overview of the PACC Guidelines supported by audio translation from expert faculty. Clinicians can easily utilize this application in daily practice to support the proper, efficacious, and safe use of intrathecal therapy, including dosing, trailing, and titration when initiating intrathecal drug delivery for patients with refractory chronic pain.
At the end of this CE activity, participants should be able to:
- Utilize evidence-based recommendations from the 2017 PACC to support the proper, efficacious and safe use of intrathecal analgesics.
- Apply dosing, trailing, and titration recommendations from the 2017 PACC when initiating intrathecal drug delivery for patients with refractory chronic pain.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Summarize evidence-based recommendations from the 2017 PACC to support the proper, efficacious and safe use of intrathecal analgesics.
- Describe dosing, trailing, and titration recommendations from the 2017 PACC when initiating intrathecal drug delivery for patients with refractory chronic pain.
Supported by an educational grant from Jazz Pharmaceuticals, Inc.
Interventional pain specialists, physicians, physician assistants, nurse practitioners, and other members of the healthcare team.
CME Credit (Physicians):
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC and the International Neuromodulation Society. CME Outfitters, LLC, is accredited by the ACCME to provide continuing medical education for physicians.
CME Outfitters, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours
Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Deer disclosed that he is on the speakers bureau for Jazz Pharmaceuticals Inc. He is also a consultant for Flowonix Medical Inc and SpineThera, Inc.
Dr. McDowell disclosed that he receives research support from Flowonix Medical Inc.; Jazz Pharmaceuticals; Mallinckrodt Pharmaceuticals; and Medtronic. He is on the speakers bureau for Jazz Pharmaceuticals and Medtronic, and is a consultant for Flowonix Medical Inc.
Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).